Related Experiment Video
Updated: May 22, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Cystoid macular edema induced by nab-paclitaxel
Yuko Tanaka1, Hiroko Bando, Hisato Hara
1Department of Breast, Thyroid and Endocrine Surgery, Tsukuba University, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan, choshi_sai_yuu@k6.dion.ne.jp.
Abstract:
Cystoid macular edema (CME) is a rare complication of taxane-based chemotherapy. We encountered a patient who developed CME during treatment with nab-paclitaxel for metastatic breast cancer. Early detection of this disease enables continuation of appropriate treatment without reducing the quality of life for patients with end-stage disease. Physicians should be aware of this potential adverse effect, and should make changes to the treatment of patients as soon as possible.
